ARQT
Arcutis Biotherapeutics, Inc. Common Stock
$26.23
-1.69%
-0.45
Notify me if price changes either direction
Buy ARQT stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
3.2B
Enterprise value
3.1B
Trailing PE
-22.586207554258
Forward PE
55.40752
PEG Ratio
0.19111406392065
Enterprise to EBITDA
-94.369
Enterprise to revenue
9.851
Price to book MRQ
19.939117
Price to sales TTM
10.094378
Financials
Fiscal Year Ends
2024-12-31
Most Recent Quarter (MRQ)
2025-09-30
Revenue (TTM)
317.9M
EBITDA
-33189000
Diluted EPS TTM
-0.34
Total Cash (MRQ)
191.1M
Current ratio (MRQ)
3.5
Operating Cash Flow (TTM)
-32558000
ARQT trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
January 2026
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
